Silco Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Silco Pharmaceuticals has a total shareholder equity of BDT2.3B and total debt of BDT0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are BDT2.8B and BDT468.5M respectively. Silco Pharmaceuticals's EBIT is BDT56.0M making its interest coverage ratio 198.1. It has cash and short-term investments of BDT62.2M.
Key information
0%
Debt to equity ratio
৳0
Debt
| Interest coverage ratio | 198.1x |
| Cash | ৳62.22m |
| Equity | ৳2.35b |
| Total liabilities | ৳468.50m |
| Total assets | ৳2.82b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SILCOPHL's short term assets (BDT1.1B) exceed its short term liabilities (BDT306.6M).
Long Term Liabilities: SILCOPHL's short term assets (BDT1.1B) exceed its long term liabilities (BDT161.9M).
Debt to Equity History and Analysis
Debt Level: SILCOPHL is debt free.
Reducing Debt: SILCOPHL had no debt 5 years ago.
Debt Coverage: SILCOPHL has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: SILCOPHL has no debt, therefore coverage of interest payments is not a concern.